New global test will give result of Coronavirus 'in minutes' | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
The Business Standard

Thursday
November 30, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
THURSDAY, NOVEMBER 30, 2023
New global test will give result of Coronavirus 'in minutes'

Coronavirus chronicle

TBS Report
29 September, 2020, 09:15 am
Last modified: 29 September, 2020, 09:25 am

Related News

  • Russia's new nuclear submarine test launches Bulava intercontinental missile
  • Many have dengue despite negative antigen test: Study
  • Coronavirus origins still a mystery 3 years into pandemic
  • North South University and ideSHi organise successful Thalassemia awareness and free carrier screening programme
  • Covid remains a public health emergency, says WHO

New global test will give result of Coronavirus 'in minutes'

The quick and easy but high-quality tests will allow mass screening of health workers, who are dying in disproportionate numbers in low income countries

TBS Report
29 September, 2020, 09:15 am
Last modified: 29 September, 2020, 09:25 am
Covid-19 novel coronavirus testing kits are packaged on a production line at the SD Biosensor bio-diagnostic company near Cheongju, South Korea. Photo: Getty Images via The Guardian
Covid-19 novel coronavirus testing kits are packaged on a production line at the SD Biosensor bio-diagnostic company near Cheongju, South Korea. Photo: Getty Images via The Guardian

Tests for Covid-19 which will show results in 15 to 30 minutes are about to be spread across the world.

This will slow the pandemic in poor as well as rich countries and potentially save thousands of lives, reports The Guardian.

In a triumph for a global initiative to get vital drugs and vaccines to fight the virus, 120m rapid antigen tests from two companies will be supplied to low- and middle-income countries for $5 (£3.90) each or even less.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Novel coronavirus “happened naturally”: WHO chief

The tests, which look like a pregnancy test, with two blue lines displayed for positive, are read by a health worker. One test has received emergency approval from the World Health Organization (WHO) and the other is expected to get it shortly.

The quick and easy but high-quality tests will allow mass screening of health workers, who are dying in disproportionate numbers in low income countries.

Wealthy countries that have signed up to the Access to Covid tools initiative (ACT accelerator), as the UK has, will also be able to order the tests. The initiative was launched in March by the WHO, the European commission, the Gates Foundation and the French government.

In return for a volume guarantee from the Gates Foundation, the companies are making 20% of their production available to low- and middle-income countries and 80% to the rest. Germany has already ordered 20m tests and France and Switzerland are following suit.

The UK government is keen to get rapid virus tests, which were central to the "moonshot" proposals leaked recently, but it is not clear if they intend to buy these tests. It has invested in British-made saliva tests as well as rapid antigen tests, both of which take about 90 minutes. Saliva tests are being trialled in Salford and Southampton, while DnaNudge, which uses a swab read by a Nudgebox, is in use in some NHS hospitals.

But the WHO-approved rapid antigen tests are faster and easier, as well as cheaper, and could be used for screening in schools, universities and workplaces. Countries that can afford it could screen more generally. While the tests will not pick up all cases, they could allow many infectious people to be identified before they have symptoms and go into quarantine.

One of the tests, from the South Korean company SD BioSensor, has just been given emergency approval by the WHO, while the other, from the US company Abbott, is expected to get it shortly for a test it manufactures in South Korea.

Catharina Boehme, CEO of the non-profit Foundation for Innovative New Diagnostics (Find), a key player in the initiative, said they had put in bulk orders for the tests quickly so that low- and middle-income countries would not lose out in the global scramble for rapid tests, as they did when the PCR tests came out. "We see the pressure of supply building rapidly. That's why we need this volume guarantee. We needed to secure volumes for low- and middle-income countries, before all the other countries place their orders and the poor populations again lose out.

"For us the message is about unprecedented collaboration. We are really able to show what can be achieved when the world and leading global health partners come together with a shared priority."

Also in the partnership that has secured the deal are the Africa Centres for Disease Control and Prevention, the Clinton Health Access Initiative, the Global Fund and Unitaid.

Peter Sands, executive director of the Global Fund, said: "This is the ACT-Accelerator in action. It is proof that by working together at a massive global scale, we can develop and deploy a vital new tool to help contain and fight the pandemic. This is not just a new test – it's the money and the deployment plan to get it to where it's needed, fast. This is the power of global collaboration."

The companies claim their tests are about 97% accurate, but that is in optimal conditions. Find puts their sensitivity between 80% and 90% in real-world conditions. That would pick up most infections. There is relatively little testing in most low- and middle-income countries at present. While North America tests 395 people per 100,000 population daily and Europe tests 243, Africa tests fewer than 16 – and most of those are in Morocco, Kenya and Senegal.

There are rapid antigen tests available for sale online, but these are the first to meet the WHO's specifications and some tests have fallen short. Spain had to send back two batches of rapid tests it bought from unlicensed companies in China in March, because they were said to be faulty.

The ACT accelerator initiative is also working on bulk-buying and distributing drugs to treat Covid-19 around the world – and will share its global portfolio of vaccines when one of them is proved to work.

Top News / World+Biz

Coronavirus / test

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Representational Image. Photo: Collected
    Electoral code violation: EC sends show cause notice to 21 candidates, most from AL
  • BNP Vice Chairman Shahjahan Omar. Photo: UNB
    Shahjahan Omar walks out of jail, leaves BNP, submits nomination for Jhalakathi-1 as AL candidate
  • File Photo of Prime Minister Sheikh Hasina
    JS polls: 7 candidates set to compete against PM Hasina for Gopalganj-3 seat

MOST VIEWED

  • TBS file photo
    Over 50 lakh Bangladeshis living abroad: Census
  • Despite some positives like, changes in wordings the major things workers demand have not been reflected in the amendments. Photo: TBS
    Bangladesh could be target of US labour policy, warns Washington mission
  • Taka appreciated officially, market reacts quite opposite
    Taka appreciated officially, market reacts quite opposite
  • Mominul Islam. File Photo: Courtesy
    IPDC CEO Mominul to step down after 4 terms
  • Only approved appraisers to assess loan collateral: Cenbank 
    Only approved appraisers to assess loan collateral: Cenbank 
  • File Photo: Reuters
    Reserves now at $19.52 billion: Bangladesh Bank

Related News

  • Russia's new nuclear submarine test launches Bulava intercontinental missile
  • Many have dengue despite negative antigen test: Study
  • Coronavirus origins still a mystery 3 years into pandemic
  • North South University and ideSHi organise successful Thalassemia awareness and free carrier screening programme
  • Covid remains a public health emergency, says WHO

Features

Photo: Nayem Ali

Falling into brown

5h | Features
Illustartion:TBS

Low tax-GDP ratio: Reluctant taxpayers, faulty structure

12h | Panorama
Illustration: TBS

I am afraid even to post a thank you note on Facebook: Khadija

12h | Panorama
Sketch: TBS

Towards a brighter tomorrow: India's G20 presidency and the dawn of a new multilateralism

11h | Panorama

More Videos from TBS

How much aid has entered Gaza?

How much aid has entered Gaza?

1h | TBS World
The maximum interest rate for NBFI loans is 13.18%

The maximum interest rate for NBFI loans is 13.18%

2h | TBS Economy
Loan disbursements through agent banking rise 60%

Loan disbursements through agent banking rise 60%

5h | TBS Economy
Circus Village

Circus Village

24m | TBS Stories
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net